Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
837.3 USD | +0.66% | +2.73% | +43.64% |
08:15am | US FDA Staff Flags Potential Limited Benefit of Eli Lilly's Alzheimer's Disease Drug | MT |
Jun. 06 | US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug | RE |
ETFs positioned on Eli Lilly and Company
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.49% | 17 M€ | +8.41% | - | |
3.30% | 92 M€ | +0.06% | - | |
3.20% | 2 M€ | -.--% | - | |
3.19% | 9 M€ | -.--% | - | |
2.82% | 3 M€ | +7.32% | - | |
2.82% | 13 M€ | -.--% | - | |
2.82% | 1 M€ | +11.94% | - | |
2.71% | 5 M€ | -72.95% | - | |
2.70% | 105 M€ | 0.00% | - | |
2.58% | 786 M€ | -.--% | ||
2.58% | 23 M€ | -.--% | - | |
2.56% | 284 M€ | -.--% | ||
2.18% | 2 M€ | +14.69% | - | |
1.98% | 219 M€ | +17.17% | - | |
1.98% | 1,448 M€ | -.--% | - | |
1.96% | 36 M€ | +22.19% | ||
1.95% | 2 M€ | +9.08% | ||
1.86% | 9 M€ | -4.31% | - | |
1.78% | 8 M€ | 0.00% | ||
1.70% | 1 M€ | +0.04% | ||
1.57% | 1,848 M€ | +18.39% | - | |
1.57% | 559 M€ | +14.30% | ||
1.49% | 273 M€ | -.--% | ||
1.49% | 655 M€ | -.--% | - | |
1.49% | 1,174 M€ | +23.54% | ||
1.46% | 414 M€ | +13.07% | - | |
1.46% | 1,006 M€ | -.--% | - | |
1.41% | 29 M€ | -.--% | - | |
1.41% | 322 M€ | +13.88% | - | |
1.24% | 85 M€ | +16.00% | - | |
1.21% | 276 M€ | +11.40% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.64% | 754B | |
+39.97% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
+11.87% | 217B | |
-1.80% | 216B | |
+0.03% | 163B | |
+6.13% | 164B | |
+0.95% | 124B |
- Stock Market
- Equities
- LLY Stock
- Funds and ETFs Eli Lilly and Company